| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Article |
1 Department of Clinical Research, Olmsted Medical Center, Rochester, Minn
2 Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minn
CORRESPONDING AUTHOR: Barbara Yawn, MD, MSc, Department of Research, Olmsted Medical Center, 210 Ninth Street SE, Rochester, MN 55904, Yawnx002{at}umn.edu
BACKGROUND Chronic hepatitis C, a treatable condition caused by the hepatitis C virus (HCV), can be found in almost all primary care and community practices. The rate of hepatitis C treatment is low, however. This study explores the frequency of hepatitis C treatment, documented discussions of treatment consideration, and the reasons treatment may not be offered in a community population.
METHODS This study is a retrospective medical record review of care provided to all patients in Olmsted County, Minn, who had a confirmed diagnosis of hepatitis C. Using all records from all health care providers in Olmsted County, the rates of documented discussions regarding hepatitis C treatment and the treatment rates by specialty of diagnosing physician were assessed. In addition, comorbidities listed as reasons not to treat and or comorbid conditions in patients without a documented treatment discussion were assessed.
RESULTS Of the 366 patients with hepatitis C, 62% were men. Hepatitis C was more commonly diagnosed by generalist physicians (41% of cases). Treatment discussions were documented for 77% of patients with hepatitis C diagnosed by either a generalist or a gastrointestinal specialist (gastroenterologist or hepatologist) compared with 46% of patients with hepatitis C diagnosed by other physicians. Generalists’ patients were more likely to have documented contraindications to treatment and were only one half as likely to receive hepatitis C treatment compared with patients with hepatitis C diagnosed by gastrointestinal specialists (16% vs 33%). Documented attempts to treat or reassess after resolution of potentially reversible contraindications to hepatitis C therapy were infrequent.
CONCLUSIONS In this community population, hepatitis C treatment was discussed with the majority of patients with a diagnosis of hepatitis C; however, the actual treatment rate was low. Many opportunities exist for treating more patients for HCV infection, particularly those found during emergency care and chemical dependency treatment. In addition, generalists’ recognition and treatment of potentially reversible contraindications to hepatitis C therapy could greatly increase the number of treatment candidates.
Key Words: Hepatitis C, chronic • primary health care • community health planning
This article has been cited by other articles:
|
|
 |
|
  M. T. Nguyen, S. K. Herrine, C. A. Laine, K. Ruth, and D. S. Weinberg Description of a New Hepatitis C Risk Assessment Tool Arch Intern Med, September 26, 2005; 165(17): 2013 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Yawn and P. Wollan Interrater Reliability: Completing the Methods Description in Medical Records Review Studies Am. J. Epidemiol., May 15, 2005; 161(10): 974 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Stange The Future of Family Medicine? Reflections from the Front Lines Reveal Frustration and Opportunity Ann. Fam. Med, May 1, 2004; 2(3): 274 - 277. [Full Text] [PDF]
|
|
|
|
|
|
W. R. Phillips In This Issue: Research in the Community and Clinic Ann. Fam. Med, March 1, 2004; 2(2): 98 - 100. [Full Text] [PDF]
|
|
Read all TRACK Comments
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
